Literature DB >> 6752167

Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.

G T Tindall, K Kovacs, E Horvath, M O Thorner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6752167     DOI： 10.1210/jcem-55-6-1178

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  34 in total

1.  Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.

Authors:  E Thodou; G Kontogeorgos; E Kyrodimou; H Salla; L Ramyar; E Vamvassakis; G Piaditis; N Anagnostopoulos; S Tzanis; A Levedis; D Rologis; S L Asa
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization.

Authors:  K Kovacs; L Stefaneanu; E Horvath; R V Lloyd; I Lancranjan; M Buchfelder; R Fahlbusch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas.

Authors:  G Schettini; G Lombardi; B Merola; P Miletto; C Fariello; S Cirillo; R Fusco; I Lancranjan
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

4.  Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.

Authors:  Giovanna Aparecida Balarini Lima; Evelyn de Oliveira Machado; Cintia Marques Dos Santos Silva; Paulo Niemeyer Filho; Mônica Roberto Gadelha
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 5.  Pharmacologic resistance in prolactinoma patients.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 6.  Human pituitary adenomas. Recent advances in morphological studies.

Authors:  G Giannattasio; M Bassetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

7.  The effect of cabergoline on clinical and laboratory findings in active rheumatoid arthritis.

Authors:  M Mobini; Z Kashi; A R Mohammad Pour; E Adibi
Journal:  Iran Red Crescent Med J       Date:  2011-10-01       Impact factor: 0.611

Review 8.  Medical management of pituitary adenomas: structural and ultrastructural changes.

Authors:  Sylvia L Asa; Shereen Ezzat
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

9.  Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. A histologic, immunocytologic and ultrastructural study of the surgically-removed adenohypophysis.

Authors:  K Kovacs; E Horvath; M O Thorner; A D Rogol
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

10.  Intratumoural cyst formation in pituitary macroadenomas.

Authors:  Z Ram; M Hadani; M Berezin; G Findler; A Sahar; I Shacked
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.